Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Dutasteride improved both hair loss and acne in two young men.

Detecting steroid esters in cattle hair is inconsistent and influenced by sampling factors.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Uterine transplants for transgender women are feasible but need more research.

Sex hormones, especially androgens, play a key role in causing acne.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Adult female acne is complex and requires a combination of treatments for effective management.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The birth control pill with only progestogen can cause a false alarm in a hormone test.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

More research is needed to determine if iron deficiency causes hair loss.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Hidradenitis suppurativa improves with antiandrogen therapy.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.